Hepatocellular Carcinoma

Hepatocellular Carcinoma is the indication for 9 drugs in DrugBank. It is covered by 12 curated, structured indications.

Also known as: Carcinoma, Hepatocellular · Liver Carcinoma · Hepatocellular Carcinoma (HCC) · Liver Cell Carcinoma · Hepato Cellular Carcinoma (HCC)
Classified under: Digestive System Diseases
Neoplasms
Indicated drugs: Cabozantinib
Capecitabine
Ethiodized oil
Hyaluronidase (human recombinant)
Ipilimumab
Nivolumab
Pembrolizumab
Ramucirumab
Regorafenib

Resolves to

Vocabularies

MeSHM0010236ICD-10C22.0SNOMED CT109841003MedDRA10019703UMLSC0023903

What you can answer from here — as of October 22, 2026

9Indicated drugsWith each drug's targets and mechanism

Listed above

12Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

2,313Clinical trialsPhase, status and sponsor resolved per trial

3Contraindicated drugsDrugs whose labels contraindicate them in this condition

7Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Hepatocellular Carcinoma share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.